The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
about
A novel cinnamic acid derivative that inhibits Cdc25 dual-specificity phosphatase activity.The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer.Cisplatin-functionalized silica nanoparticles for cancer chemotherapy.Ormaplatin resistance is associated with decreased accumulation of its platinum (II) analogue, dichloro(D,L-trans)1,2-diaminocyclohexaneplatinum (II).Predicting chemotherapeutic response to small-cell lung cancer of platinum compounds by thallium-201 single-photon emission computerized tomographyAnti-tumour activities of a new benzo[c]phenanthridine agent, 2,3-(methylenedioxy)-5-methyl-7-hydroxy-8-methoxybenzo[c]phena nthridini um hydrogensulphate dihydrate (NK109), against several drug-resistant human tumour cell lines.Contributions of microRNA dysregulation to cisplatin resistance in adenocarcinoma cells.Intracellular uptake of an antitumor-active azole-bridged dinuclear platinum(II) complex in cisplatin-resistant tumor cells.Highly efficient uptake into cisplatin-resistant cells and the isomerization upon coordinative DNA binding of anticancer tetrazolato-bridged dinuclear platinum(II) complexes.Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.Contribution of intracellular ATP to cisplatin resistance of tumor cells.Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.Influence of SiRNA targeting survivin on chemosensitivity of H460/cDDP lung cancer cells.Paclitaxel and SN-38 overcome cisplatin resistance of ovarian cancer cell lines by down-regulating the influx and efflux system of cisplatin.Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519.Circumvention of glutathione-mediated mitomycin C resistance by a novel mitomycin C analogue, KW-2149.Intracellular carboxyl esterase activity is a determinant of cellular sensitivity to the antineoplastic agent KW-2189 in cell lines resistant to cisplatin and CPT-11.Ouabain-resistant non-small-cell lung-cancer cell line shows collateral sensitivity to cis-diamminedichloroplatinum(II) (CDDP).Differential Na+,K(+)-ATPase activity and cisplatin sensitivity between transformants induced by H-ras and those induced by K-ras.Role of glutathione in cisplatin resistance in osteosarcoma cell lines.In vitro antitumor activity of TAS-103, a novel quinoline derivative that targets topoisomerases I and II.
P2860
Q33222512-A96D9139-475A-4E84-863C-031F5BADD781Q35399165-F5BB44FD-FD8B-47DA-A585-2F6D70C86759Q35673307-25C5F66A-3438-4407-9B99-599D18307A76Q36135855-98EEE8F1-9716-4827-B7E7-EE8EED91C6DBQ36292392-AEB447ED-AD3E-48B5-B5AB-DD9E276DAE35Q36431000-FE584ACB-FA28-4F6F-A889-AEF2999106F2Q36585797-72FE93AB-2283-4167-AFE2-6E27586FA36DQ38736332-D1886659-60BF-49D7-AAD0-17BF61F4343FQ38833550-177ACA31-2912-42FC-B533-8538D3E2D433Q39162262-964A693C-F89B-431F-BC73-5833D371D7C9Q39238152-0B5C4E04-651B-40D6-A6E2-CF800C4097B7Q39927689-2B10D9EC-0197-44E1-B391-A37DE8E977B2Q39957684-064005B7-5C23-4618-B260-1F5BA811279BQ40767821-39697102-EA0B-4A5F-ACE5-F5C010937659Q40796113-C06C1D19-C657-450F-9BDE-E4258AD1ACA2Q41090317-0B6ADE6E-CC44-4E1B-B9B5-22DBC32B6B05Q41394970-BD2D7704-263A-4E8F-8E94-2C6FD3FB9669Q41475636-1A4B620B-4416-4E36-AE18-49D1FEA1645AQ42834141-14E6293C-5A28-4387-B309-0AC66763BBC5Q54076837-73F330B4-8725-4A5A-8AA5-586A508C2CDAQ54959930-451C53BC-9120-434C-9BD5-53DCF74F2BCB
P2860
The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
The mechanism of the differenc ...... esistant subline (PC-14/CDDP).
@en
type
label
The mechanism of the differenc ...... esistant subline (PC-14/CDDP).
@en
prefLabel
The mechanism of the differenc ...... esistant subline (PC-14/CDDP).
@en
P2093
P2860
P1476
The mechanism of the differenc ...... esistant subline (PC-14/CDDP).
@en
P2093
K Kasahara
T Morikage
T Takahashi
Y Fujiwara
Y Sugimoto
P2860
P356
10.1111/J.1349-7006.1993.TB02788.X
P577
1993-01-01T00:00:00Z